Sangamo Therapeutics (SGMO)
(Delayed Data from NSDQ)
$0.56 USD
+0.03 (6.48%)
Updated May 3, 2024 04:00 PM ET
After-Market: $0.55 -0.01 (-1.04%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: AMC |
3/2024 | $-0.22 | 0.00% |
Earnings Summary
For their last quarter, Sangamo Therapeutics (SGMO) reported earnings of -$0.34 per share, missing the Zacks Consensus Estimate of -$0.25 per share. This reflects a negative earnings surprise of 36.00%. Look out for SGMO's next earnings release on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.22 per share, reflecting a year-over-year decrease of 283.33%.
Earnings History
Price & Consensus
Zacks News for SGMO
Sangamo Therapeutics (SGMO) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
SGMO: What are Zacks experts saying now?
Zacks Private Portfolio Services